Microbot Medical Inc. (MBOT) Earnings History
Annual and quarterly earnings data from 1991 to 2024
Loading earnings history...
MBOT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MBOT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export MBOT earnings history in CSV or JSON format
Free sign-in required to download data
Microbot Medical Inc. (MBOT) Earnings Overview
As of May 8, 2026, Microbot Medical Inc. (MBOT) reported trailing twelve-month net income of -$13M, reflecting +30.5% year-over-year growth. The company earned $-0.27 per diluted share over the past four quarters.
Looking at the long-term picture, MBOT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$3M in fiscal 2001.
Microbot Medical Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SSYS (-$104M net income, -18.9% margin), RBOT (-$42M net income), TRVI (-$46M net income), MBOT has comparable earnings metrics. Compare MBOT vs SSYS →
MBOT Earnings vs Peers
Earnings metrics vs comparable public companies
MBOT Historical Earnings Data (1991–2024)
34 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$11M | -6.5% | -$12M | $-0.73 | - | - |
| 2023 | -$11M | +18.4% | -$10M | $-1.05 | - | - |
| 2022 | -$13M | -16.4% | -$13M | $-1.81 | - | - |
| 2021 | -$11M | -23.4% | -$11M | $-1.59 | - | - |
| 2020 | -$9M | -26.5% | -$9M | $-1.29 | - | - |
| 2019 | -$7M | +0.2% | -$7M | $-1.70 | - | - |
| 2018 | -$7M | +4.3% | -$7M | $-0.81 | - | - |
| 2017 | -$8M | +21.5% | -$5M | $-0.85 | - | - |
| 2016 | -$10M | +73.5% | -$10M | $-10.14 | - | - |
| 2015 | -$36M | -11.2% | -$37M | $-7.20 | -31123.9% | -31384.6% |
See MBOT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MBOT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MBOT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMBOT — Frequently Asked Questions
Quick answers to the most common questions about buying MBOT stock.
Is MBOT growing earnings?
MBOT EPS is $-0.27, with earnings growth accelerating to +30.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-13M.
What are MBOT's profit margins?
Microbot Medical Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are MBOT's earnings?
MBOT earnings data spans 1991-2024. The accelerating earnings trend is +30.5% YoY. Historical data enables comparison across business cycles.